Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01186640||Completed||Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)||
||Other / Industry||
||16||All||18 Years and older (Adult, Older Adult)||NCT01186640||T-PLL2
|June 2010||May 2014||May 2014||August 23, 2010||May 10, 2018||
|2||NCT02689453||Recruiting||Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)||
||30||All||18 Years and older (Adult, Older Adult)||NCT02689453||160062
|January 19, 2017||January 31, 2023||January 31, 2025||February 24, 2016||May 22, 2019||